HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Alterations of systemic and muscle iron metabolism in human subjects treated with low-dose recombinant erythropoietin.

Abstract
The high iron demand associated with enhanced erythropoiesis during high-altitude hypoxia leads to skeletal muscle iron mobilization and decrease in myoglobin protein levels. To investigate the effect of enhanced erythropoiesis on systemic and muscle iron metabolism under nonhypoxic conditions, 8 healthy volunteers were treated with recombinant erythropoietin (rhEpo) for 1 month. As expected, the treatment efficiently increased erythropoiesis and stimulated bone marrow iron use. It was also associated with a prompt and considerable decrease in urinary hepcidin and a slight transient increase in GDF-15. The increased iron use and reduced hepcidin levels suggested increased iron mobilization, but the treatment was associated with increased muscle iron and L ferritin levels. The muscle expression of transferrin receptor and ferroportin was up-regulated by rhEpo administration, whereas no appreciable change in myoglobin levels was observed, which suggests unaltered muscle oxygen homeostasis. In conclusion, under rhEpo stimulation, the changes in the expression of muscle iron proteins indicate the occurrence of skeletal muscle iron accumulation despite the remarkable hepcidin suppression that may be mediated by several factors, such as rhEpo or decreased transferrin saturation or both.
AuthorsPaul Robach, Stefania Recalcati, Domenico Girelli, Cecilia Gelfi, Niels J Aachmann-Andersen, Jonas J Thomsen, Anne M Norgaard, Alessandra Alberghini, Natascia Campostrini, Annalisa Castagna, Agnese Viganò, Paolo Santambrogio, Tibor Kempf, Kai C Wollert, Stéphane Moutereau, Carsten Lundby, Gaetano Cairo
JournalBlood (Blood) Vol. 113 Issue 26 Pg. 6707-15 (Jun 25 2009) ISSN: 1528-0020 [Electronic] United States
PMID19264680 (Publication Type: Clinical Trial, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antigens, CD
  • Antimicrobial Cationic Peptides
  • CD71 antigen
  • Cation Transport Proteins
  • HAMP protein, human
  • Hemoglobins
  • Hepcidins
  • Myoglobin
  • RNA, Messenger
  • Receptors, Transferrin
  • Recombinant Proteins
  • epoetin beta
  • metal transporting protein 1
  • Erythropoietin
  • Iron
Topics
  • Adult
  • Antigens, CD (genetics)
  • Antimicrobial Cationic Peptides (analysis, biosynthesis)
  • Biopsy
  • Cation Transport Proteins (genetics)
  • Down-Regulation (drug effects)
  • Erythrocyte Volume (drug effects)
  • Erythropoiesis (drug effects)
  • Erythropoietin (administration & dosage, pharmacology)
  • Hematocrit
  • Hemoglobins (analysis)
  • Hepcidins
  • Humans
  • Iron (metabolism)
  • Male
  • Muscle, Skeletal (cytology, drug effects, metabolism)
  • Myoglobin (analysis)
  • RNA, Messenger (analysis)
  • Receptors, Transferrin (genetics)
  • Recombinant Proteins
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: